```html

Zygospermia (Low Sperm Motility) – A Complete Patient Guide

Overview

Zygospermia refers to reduced forward movement of sperm cells in the ejaculate. When the percentage of motile sperm falls below 40 % (or the progressive motility falls below 32 %), the condition is called asthenozoospermia – the medical term most clinicians use for “low sperm motility.” It is a major cause of male factor infertility.

• Who it affects: Men of reproductive age (roughly 20‑45 years), but it can be identified in younger adolescents during fertility work‑ups or in older men undergoing evaluation for declining fertility.
• Prevalence: About 15‑20 % of infertile couples have a male partner with low sperm motility, and 30‑40 % of all male infertility cases involve some degree of asthenozoospermia (World Health Organization, 2021).
• Impact: Low motility reduces the chance that sperm will reach and fertilize an egg, decreasing natural conception rates to roughly 5‑15 % per month compared with 20‑30 % in couples with normal semen parameters.

Symptoms

Unlike many systemic illnesses, low sperm motility rarely produces obvious physical symptoms. The “symptoms” are usually discovered during a semen analysis ordered for a fertility evaluation. However, some men notice indirect clues:

• Difficulty conceiving: One or more years of unprotected intercourse without pregnancy.
• Reduced ejaculate volume: Occasionally < 1.5 mL, though volume is more linked to other conditions.
• Changes in ejaculatory force: A weaker “spray” may hint at underlying seminal tract issues.
• Pain, swelling, or tenderness: In the testicles, epididymis, or scrotum, which could indicate infection or varicocele that also impairs motility.
• History of fever, illness, or medication use: These can temporarily lower motility.

Causes and Risk Factors

Low motility is usually multifactorial. The following categories summarize the most common contributors.

1. Medical / Anatomical Causes

• Varicocele: Dilated veins in the scrotum raise testicular temperature, impairing sperm development.
• Infections: Epididymitis, orchitis, prostatitis, or sexually transmitted infections can damage sperm membranes.
• Hormonal Imbalances: Low testosterone, high estradiol, or abnormal FSH/LH levels disrupt spermatogenesis.
• Genetic Disorders: Klinefelter syndrome (47,XXY), Y‑chromosome microdeletions, or CFTR mutations (linked to congenital bilateral absence of the vas deferens).
• Obstructions: Blockages in the ejaculatory ducts or vas deferens can lead to abnormal semen composition.

2. Lifestyle & Environmental Factors

• Excessive heat exposure (saunas, hot tubs, tight underwear).
• Smoking – reduces motility by 20‑30 % in chronic smokers.
• Alcohol abuse – > 14 drinks/week is associated with lower progressive motility.
• Recreational drugs – marijuana and cocaine have documented negative effects.
• Obesity – BMI > 30 kg/m² correlates with a 10‑15 % drop in motile sperm.
• Occupational exposures – pesticides, heavy metals (lead, cadmium), and radiation.

3. Iatrogenic (Medication‑Induced) Causes

• Antibiotics (e.g., tetracyclines, fluoroquinolones) in high doses.
• Chemotherapy and radiotherapy.
• Hormonal treatments (anabolic steroids, testosterone replacement).
• Antidepressants (SSRIs) and anti‑psychotics – may affect seminal parameters.

4. Idiopathic

In up to 30 % of cases, no clear cause is found despite thorough evaluation. Ongoing research suggests subtle mitochondrial DNA defects or oxidative stress may play a role.

Diagnosis

Evaluating suspected low sperm motility involves a step‑wise approach.

1. Medical History & Physical Exam

• Detailed fertility timeline, medication list, past infections, surgeries, and lifestyle habits.
• Scrotal exam for varicoceles, masses, or tenderness.

2. Semen Analysis (Reference Standard)

According to the 2021 WHO laboratory manual, a standard semen analysis measures:

• Volume, pH, and liquefaction time.
• Sperm concentration (million/mL).
• Motility – total motile % and progressive motility %.
• Morphology – normal forms.

At least two samples collected 2–7 days apart are recommended to account for natural variation.
Reference values (WHO 2021):
- Total motility ≥ 40 %
- Progressive motility ≥ 32 %

3. Additional Laboratory Tests

• Hormone panel: Testosterone, FSH, LH, prolactin, estradiol.
• Genetic screening: Karyotype, Y‑chromosome microdeletion analysis, CFTR mutation testing.
• Infection work‑up: PCR for Chlamydia, Gonorrhea; urine culture.
• Oxidative stress assays: Reactive oxygen species (ROS) measurement in specialized labs.

4. Imaging

• Scrotal ultrasound: Detects varicoceles, epididymal cysts, or tumors.
• Transrectal ultrasound (TRUS): Evaluates ejaculatory ducts and seminal vesicles when obstruction is suspected.

Treatment Options

Therapy is individualized based on identified cause, severity, and the couple’s reproductive goals (natural conception vs. assisted reproductive technology, ART).

1. Lifestyle Modification (First‑line)

• Quit smoking and limit alcohol to ≤ 2 drinks/week.
• Maintain a healthy weight (BMI 18.5‑24.9 kg/m²).
• Wear loose‑fitting underwear and avoid daily hot‑tub/sauna use.
• Increase antioxidant‑rich foods (berries, nuts, leafy greens) and consider supplements (see below).

2. Medical Therapies

• Antioxidant supplements: Vitamin C 500 mg, Vitamin E 400 IU, Coenzyme Q10 200‑300 mg, Selenium 200 µg, and L‑carnitine 2 g daily have demonstrated modest improvements in motility (Cochrane Review 2022).
• Hormonal treatment: If testosterone is low, clomiphene citrate (25‑50 mg daily) or aromatase inhibitors (anastrozole 1 mg) can stimulate endogenous testosterone production.
• Empirical antibiotics: For suspected subclinical infection, a short course of doxycycline (100 mg BID for 4 weeks) is sometimes used, though evidence is limited.
• Varicocele repair: Microsurgical subinguinal varicocelectomy improves motility in 60‑70 % of men, with pregnancy rates rising to 40‑50 % within a year (Mayo Clinic, 2023).

3. Assisted Reproductive Technologies (ART)

• Intrauterine insemination (IUI): Requires a minimum of 5 million motile sperm after washing; works for mild motility deficits.
• In vitro fertilization (IVF) with conventional IVF: If > 5 million motile sperm are available, standard IVF may be successful.
• Intracytoplasmic sperm injection (ICSI): A single sperm is injected directly into an egg, making motility less critical. Recommended when motility < 5 % or when ART is already indicated.

4. Experimental / Emerging Therapies

• Platelet‑rich plasma (PRP) injections into the testes: Small pilot studies suggest improved motility, but larger trials are pending.
• Gene therapy: Still investigational for specific genetic defects (e.g., DNAH1 mutations).

Living with Zygospermia (Low Sperm Motility)

Managing the condition goes beyond medical treatment; emotional and practical aspects matter.

• Track fertility timing: Use ovulation predictor kits or basal body temperature charts to maximize the chance of intercourse during the fertile window.
• Stay informed: Keep a copy of all semen analysis reports; note trends over time.
• Emotional support: Counseling, support groups, or fertility psychologists can help couples cope with stress.
• Optimize nutrition: A Mediterranean‑style diet rich in omega‑3 fatty acids (salmon, walnuts) has been associated with better sperm motility.
• Regular follow‑up: Repeat semen analysis 3–6 months after any intervention to gauge response.
• Safe sexual practices: Use condoms consistently if there’s a concurrent STI; treat infections promptly.

Prevention

While some risk factors (genetics, previous chemotherapy) cannot be altered, many are modifiable:

• Maintain a healthy weight and exercise regularly (30 min moderate activity most days).
• Avoid exposure to known reproductive toxins—use protective equipment when handling pesticides or heavy metals.
• Limit heat exposure: avoid laptops on the lap for prolonged periods; keep phones away from the scrotum.
• Vaccinate against mumps and other infections that can cause orchitis.
• Discuss any medication changes with a physician, especially anabolic steroids or testosterone therapy.

Complications

If left untreated, low sperm motility itself does not threaten overall health, but it can lead to:

• Infertility or delayed family building, which may affect mental health and relationships.
• Increased reliance on costly ART procedures (IVF/ICSI).
• Potential underlying conditions (e.g., untreated varicocele) that may progress to testicular atrophy.
• Psychological distress, anxiety, or depression—studies show 30‑40 % of men with male factor infertility experience clinically significant depressive symptoms (Cleveland Clinic, 2022).

When to Seek Emergency Care

---

**References** (selected):

• World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 5th ed., 2021.
• Mayo Clinic. “Varicocele treatment: What to expect,” 2023.
• Cochrane Database of Systematic Reviews. “Antioxidants for male infertility,” 2022.
• American Urological Association. “Guidelines for Male Infertility,” 2022.
• Cleveland Clinic. “Mental health in male infertility,” 2022.
• NIH National Institute of Child Health & Human Development. “Infertility and Assisted Reproductive Technology,” 2024.

```